KER-012
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KER-012, covering 2025-09-30 to 2026-07-02. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study). [Phase 2]